This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Mary Samuel - Innovator in Pharmaceutical Formulations
Introduction
Mary Samuel is a notable inventor based in Lindenhurst, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on improving the efficacy and stability of medications, which is crucial for patient care.
Latest Patents
Mary Samuel holds a patent for a premixed formulation of piperacillin sodium and tazobactam sodium injection. This invention provides a premixed form of a buffered piperacillin product that has a near neutral pH and is capable of a shelf life of at least nine months when stored in a freezer at temperatures of -20°C or lower. Additionally, it can maintain a refrigerated shelf life of up to 14 days at about 5°C. The formulation includes a tazobactam component to inactivate beta-lactamases, which are known to cause resistance to penicillins, thereby allowing the piperacillin component to effectively destroy susceptible bacteria. The addition of dextrose ensures that the premixed composition is physiologically isosmotic.
Career Highlights
Mary Samuel is currently employed at Baxter International Inc., a leading global healthcare company. Her role involves research and development in pharmaceutical formulations, where she applies her expertise to create innovative solutions that enhance patient outcomes.
Collaborations
Mary collaborates with her coworker, Rao Chilamkurti, to further advance their research initiatives and develop new pharmaceutical products.
Conclusion
Mary Samuel's contributions to pharmaceutical innovations, particularly her patented formulation, demonstrate her commitment to improving healthcare solutions. Her work continues to impact the industry positively, ensuring better treatment options for patients.